{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:01:41Z","timestamp":1790618501989,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:00:00Z","timestamp":1589673600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.phrs.2019.04.034","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:57:08Z","timestamp":1556884628000},"page":"104250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Involvement of the GABAA receptor \u03b1 subunit in the mode of action of etifoxine"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-2611","authenticated-orcid":false,"given":"C\u00e9sar","family":"Mattei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5109-0091","authenticated-orcid":false,"given":"Antoine","family":"Taly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Soualah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Saulais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Henrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C.","family":"Gu\u00e9rineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Verleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-7059","authenticated-orcid":false,"given":"Christian","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.phrs.2019.04.034_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6216","key":"10.1016\/j.phrs.2019.04.034_bib0035","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","article-title":"Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology","volume":"338","author":"Pritchett","year":"1989","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF00215488","article-title":"Comparing benzodiazepines using the staircase test in mice","volume":"92","author":"Steru","year":"1987","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0045","first-page":"72","article-title":"Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models","volume":"17","author":"Bourin","year":"1992","journal-title":"J. Psychiatry Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.034_bib0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6755","key":"10.1016\/j.phrs.2019.04.034_bib0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.034_bib0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"5489","key":"10.1016\/j.phrs.2019.04.034_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6we","year":"2000","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.phrs.2019.04.034_bib0070","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.04.034_bib0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/7854_2009_30","article-title":"GABAA receptor alpha2\/alpha3 subtype-selective modulators as potential nonsedating anxiolytics","volume":"2","author":"Atack","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.npp.1301403","article-title":"Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?","volume":"33","author":"Savic","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.phrs.2019.04.034_bib0085","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic\u2019 Restriction-of-Function\u2019 approach reveals evidence for anxiolytic-like actions mediated by alpha5-Containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0090","first-page":"325","article-title":"[Experimental psychopharmacologic study of a new psychotropic drug, 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine]","volume":"27","author":"Boissier","year":"1972","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12325-015-0176-6","article-title":"Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial","volume":"32","author":"Stein","year":"2015","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/j.1532-2149.2013.00367.x","article-title":"Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy","volume":"18","author":"Aouad","year":"2014","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-016-0687-3","article-title":"Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury","volume":"13","author":"Simon-O\u2019Brien","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.phrs.2019.04.034_bib0115","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0028-3908(99)00253-1","article-title":"Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine","volume":"39","author":"Schlichter","year":"2000","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.034_bib0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pbb.2005.11.013","article-title":"The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain","volume":"82","author":"Verleye","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.phrs.2019.04.034_bib0130","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/acschemneuro.7b00027","article-title":"The anxiolytic etifoxine binds to TSPO Ro5-4864 binding site with long residence time showing a high neurosteroidogenic activity","volume":"8","author":"Costa","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2019.04.034_bib0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.psyneuen.2017.05.022","article-title":"Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: pharmacodynamic studies","volume":"83","author":"Liere","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"15","key":"10.1016\/j.phrs.2019.04.034_bib0140","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1097\/00001756-199910190-00015","article-title":"Interactions of etifoxine with the chloride channel coupled to the GABA(A) receptor complex","volume":"10","author":"Verleye","year":"1999","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.034_bib0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-007-1066-7","article-title":"Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb\/cByJ mice using GABA A-related mechanistic probes","volume":"197","author":"Verleye","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2003.09.010","article-title":"Effects of stress and etifoxine on pentobarbital-induced loss of righting reflex in Balb\/cByJ and C57BL\/6J mice","volume":"353","author":"Verleye","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0155","first-page":"125","article-title":"Benzodiazepines and amphetamine on avoidance behaviour in mice","volume":"218","author":"Sansone","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.034_bib0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01673550","article-title":"Effect of a new benzodiazepine bromazepam on locomotor performance and brain monoamine metabolism","volume":"42","author":"Rastogi","year":"1978","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.034_bib0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2010.09.008","article-title":"Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB\/cByJ and C57BL\/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits?","volume":"21","author":"Verleye","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2019.04.034_bib0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(03)01326-8","article-title":"Stress-induced hyperthermia and anxiety: pharmacological validation","volume":"463","author":"Olivier","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0031-9384(94)90017-5","article-title":"Stress-induced hyperthermia in mice: a methodological study","volume":"55","author":"Zethof","year":"1994","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0031-9384(97)00157-1","article-title":"Stress-induced hyperthermia in singly housed mice","volume":"62","author":"Van der Heyden","year":"1997","journal-title":"Physiol. Behav."},{"issue":"1-3","key":"10.1016\/j.phrs.2019.04.034_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(03)01278-0","article-title":"Defensive burying in rodents: ethology, neurobiology and psychopharmacology","volume":"463","author":"De Boer","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.plasmid.2008.02.002","article-title":"A method for generating sticky-end PCR products which facilitates unidirectional cloning and the one-step assembly of complex DNA constructs","volume":"59","author":"Walker","year":"2008","journal-title":"Plasmid"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00424-006-0183-1","article-title":"Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus","volume":"454","author":"Venkatachalan","year":"2007","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.034_bib0200","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0896-6273(90)90337-F","article-title":"Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+","volume":"5","author":"Draguhn","year":"1990","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jmbi.2000.4042","article-title":"T-Coffee: a novel method for fast and accurate multiple sequence alignment","volume":"302","author":"Notredame","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0210","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.034_bib0215","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/prot.22488","article-title":"Improved prediction of protein side-chain conformations with SCWRL4","volume":"77","author":"Krivov","year":"2009","journal-title":"Proteins"},{"issue":"10","key":"10.1016\/j.phrs.2019.04.034_bib0220","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.034_bib0225","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bpj.2014.03.024","article-title":"A predicted binding site for cholesterol on the GABAA receptor","volume":"106","author":"Henin","year":"2014","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2019.04.034_bib0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2007.09.041","article-title":"Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats","volume":"1184","author":"Ugale","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.04.034_bib0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fncel.2011.00006","article-title":"Impact of synaptic neurotransmitter concentration time course on the kinetics and pharmacological modulation of inhibitory synaptic currents","volume":"5","author":"Barberis","year":"2011","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.034_bib0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuropharm.2010.07.011","article-title":"Benzodiazepine modulation of the rat GABAA receptor alpha4beta3gamma2L subtype expressed in Xenopus oocytes","volume":"59","author":"You","year":"2010","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2019.04.034_bib0250","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1523\/JNEUROSCI.18-05-01693.1998","article-title":"Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells","volume":"18","author":"Nusser","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.04.034_bib0255","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: resources for positioning of proteins in membranes","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res 40(Database issue)"},{"key":"10.1016\/j.phrs.2019.04.034_bib0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2015.11.042","article-title":"A microPET comparison of the effects of etifoxine and diazepam on [(11)C]flumazenil uptake in rat brains","volume":"612","author":"Bouillot","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.034_bib0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2885.2002.00442.x","article-title":"Free drug fraction vs free drug concentration: a matter of frequent confusion","volume":"25","author":"Toutain","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/dmd.104.001222","article-title":"Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice","volume":"33","author":"Maurer","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"20","key":"10.1016\/j.phrs.2019.04.034_bib0280","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.0502579102","article-title":"Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator","volume":"102","author":"Lippa","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.phrs.2019.04.034_bib0285","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0031-9384(04)00313-0","article-title":"Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats","volume":"82","author":"Verleye","year":"2004","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00181936","article-title":"Antagonism by exifone, a new cognitive enhancing agent, of the amnesias induced by four benzodiazepines in mice","volume":"95","author":"Porsolt","year":"1988","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2001.00025.x","article-title":"A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected]","volume":"15","author":"Micallef","year":"2001","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.034_bib0300","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.euroneuro.2018.05.011","article-title":"Etifoxine impairs neither alertness nor cognitive functions of the elderly: a randomized, double-blind, placebo-controlled crossover study","volume":"28","author":"Deplanque","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0034-1398507","article-title":"Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.034_bib0310","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0028-3908(02)00172-7","article-title":"The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors","volume":"43","author":"Belelli","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.04.034_bib0315","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0320","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.034_bib0325","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1152\/jn.00539.2013","article-title":"EEG-beta\/gamma spectral power elevation in rat: a translatable biomarker elicited by GABA(Aalpha2\/3)-positive allosteric modulators at nonsedating anxiolytic doses","volume":"113","author":"Christian","year":"2015","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.034_bib0330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00213-010-2142-y","article-title":"Contribution of GABA(A) receptors containing alpha3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys","volume":"215","author":"Fischer","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.034_bib0335","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA alpha5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"40","key":"10.1016\/j.phrs.2019.04.034_bib0340","doi-asserted-by":"crossref","first-page":"41422","DOI":"10.1074\/jbc.M401354200","article-title":"Analysis of the set of GABA(A) receptor genes in the human genome","volume":"279","author":"Simon","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7712","key":"10.1016\/j.phrs.2019.04.034_bib0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:59:15Z","timestamp":1760911155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818318061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":69,"alternative-id":["S1043661818318061"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.034","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the GABAA receptor \u03b1 subunit in the mode of action of etifoxine","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104250"}}